Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548639 · ClinicalTrials.gov registry record · NA
The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT00548639 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 152 participants.
The verdict
NCT00548639, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
Diabetes is a growing epidemic within the United States that disproportionately affects economically disadvantaged communities like East Harlem. As diabetic patients are at very high risk for heart disease, experts recommend an aggressive approach towards using statins in people with diabetes. However, statins and other helpful drugs are only effective if patients decide to take them. Adherence to this medication is notoriously poor and is aggravated by its required life-long use. This study is designed to test the effectiveness of a new decision aid in helping diverse, inner-city patients with diabetes understand the risks and benefits in taking statins and whether this enhanced decision making process improves their adherence to the medication.
Interventions
- OTHER Statin Choice Decision Aid
- OTHER Control Pamphlet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00548639
The ClinicalTrials.gov registry entry for NCT00548639 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Statin Choice Decision Aid is the first listed.
NCT00548639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00548639 about?
NCT00548639 is a clinical study titled "The STATIN CHOICE Decision Aid for Type 2 Diabetes Patients". Diabetes is a growing epidemic within the United States that disproportionately affects economically disadvantaged communities like East Harlem. As diabetic patients are at very high risk for heart disease, experts recommend an aggressive approach towards using statins in people with diabetes. Howev...
What is the current status of trial NCT00548639?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2007-08. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00548639?
The interventions under investigation include: Statin Choice Decision Aid (OTHER), Control Pamphlet (OTHER).
Who is sponsoring clinical trial NCT00548639?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.